Product Information

AMOX-CLAV 400-57 MG/5 ML SUSP is a generic product labeled by Sandoz Inc., priced at $0.0565 per ML under NDC 00781610446. Its NADAC has been published 530 times since Sep 7, 2016.

FDA first approved this application on Jun 5, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMOX-CLAV 400-57 MG/5 ML SUSP

Amoxicillin and Clavulanate Potassium
$0.0565per ML

Strength

400; 57 mg/5mL; mg/5mL

Manufacturer

Sandoz Inc.

NDC

00781610446

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA065066

FDA Approved

6/5/2002

TE Code

AB

On Market Since

6/5/2002

Pharmacological Classes

Penicillin-class Antibacterial
Penicillins
beta Lactamase Inhibitor
beta Lactamase Inhibitors

Price Statistics

The NADAC for AMOX-CLAV 400-57 MG/5 ML SUSP has been published 530 times since Sep 7, 2016, and over the history we have for it it has declined 52.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0565 per ML
All-time high$0.1182 (Sep 14, 2016)
All-time low$0.0539 (Jul 17, 2024)
52-week high$0.0631
52-week low$0.0556
Median price$0.0739
Average price$0.0760
Largest weekly change+27.5% (Aug 21, 2024)
Weeks tracked530
Tracking sinceSep 7, 2016

Price History

1W

+1.5%

1M

+0.5%

3M

-0.5%

6M

-4.9%

1Y

-10.6%

3Y

-5.4%

5Y

-23.7%

All

-52.2%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AMOX-CLAV 400-57 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for AMOX-CLAV 400-57 MG/5 ML SUSP, manufactured by Sandoz Inc., is $0.0565 per ML (NDC 00781610446), effective Nov 18, 2026.

How has the price of AMOX-CLAV 400-57 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for AMOX-CLAV 400-57 MG/5 ML SUSP has declined 52.2%. It has been tracked across 530 weekly CMS publications since Sep 7, 2016.

What are the highest and lowest recorded NADAC prices for AMOX-CLAV 400-57 MG/5 ML SUSP?

Since Sep 7, 2016, the NADAC for AMOX-CLAV 400-57 MG/5 ML SUSP has ranged from a low of $0.0539 (Jul 17, 2024) to a high of $0.1182 (Sep 14, 2016), with a median of $0.0739 per ML.

Are there cheaper alternatives to AMOX-CLAV 400-57 MG/5 ML SUSP?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMOX-CLAV 400-57 MG/5 ML SUSP, is $0.0562 per ML — about 1% below AMOX-CLAV 400-57 MG/5 ML SUSP.

Who manufactures AMOX-CLAV 400-57 MG/5 ML SUSP?

AMOX-CLAV 400-57 MG/5 ML SUSP (NDC 00781610446) is labeled by Sandoz Inc., and CMS classifies it as a generic product.